Clinical Trial Detail

NCT ID NCT02665143
Title A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Yale University
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin

Nintedanib

Age Groups: adult

No variant requirements are available.